Biogen Has Up to $10 billion for Next M&A Bets: Bloomberg Deals

Hi, welcome to the Bloomberg Deals newsletter. In today’s edition, we’re chatting with the CFO of Biogen about the company’s near-term M&A plans. Elsewhere, KKR’s Johannes Huth is retiring.

Today’s top stories

• Arnault buys stake in Cartier owner Richemont.
• Boeing’s Spirit Aero bid values 737 supplier at $35 a share.
• European IPOs cling to gains as listing revival falters.
• UniCredit competing with OTP in bidding for Blackstone’s Luminor.
• KKR’s EMEA chairman Huth retires after 25 years at firm.

Biogen bets

On the heels of its up to $1.8 billion deal for Human Immunology Biosciences, Biogen is already looking for new targets, with finance ...